DNA methylation-based prognostic biomarkers of acute myeloid leukemia patients

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous clonal disease that prevents normal myeloid differentiation with its common features. Its incidence increases with age and has a poor prognosis. Studies have shown that DNA methylation and abnormal gene expression are closely related to AML...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Transl Med
Egile Nagusiak: Hu, Linjun, Gao, Yuling, Shi, Zhan, Liu, Yang, Zhao, Junjun, Xiao, Zunqiang, Lou, Jiayin, Xu, Qiuran, Tong, Xiangmin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989983/
https://ncbi.nlm.nih.gov/pubmed/32042753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.11.122
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak